(Photo: AFP) Indian stock market ... Tyson Foods shares gained 2.2%, while IDEXX Laboratories jumped 11.1%. US President Donald Trump has agreed to pause planned tariffs for at least a month ...

Shares of IDEXX Laboratories Inc. IDXX rallied 1.02% to $449.06 Tuesday, on what proved to be an all-around positive trading ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX)’s share price is up by 2.6% over the past month. Over the past five years, IDEXX has been up 50% in the last five years, which is less than the market ...

Idexx delivered revenue and EPS growth of 6% and 13% in Q4, but its guidance appears to have caught the market's attention. Looking ahead to 2025, management expects the company to grow sales by 4 ...

Shares of IDEXX Laboratories Inc. IDXX slid 3.31% to $444.53 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 ...

Good morning, and welcome to the IDEXX Laboratories' Fourth Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded. Participating in the call this morning are ...

Veterinary diagnostics specialist Idexx Laboratories (NASDAQ:IDXX) reported fourth-quarter earnings on Monday, Feb. 3, that topped analysts' consensus top- and bottom-line estimates. Revenue for ...

In its fourth quarter 2024 investor letter, Baron Asset Fund emphasized stocks such as IDEXX Laboratories, Inc. (NASDAQ:IDXX). IDEXX Laboratories, Inc. (NASDAQ:IDXX) develops, manufactures ...

Idexx Laboratories (IDXX) came out with quarterly earnings of $2.62 per share, beating the Zacks Consensus Estimate of $2.40 per share. This compares to earnings of $2.32 per share a year ago.

In a new SEC filing on February 11, it was revealed that Fennell, Executive Vice President at IDEXX Laboratories IDXX, executed a significant exercise of company stock options. What Happened ...

IDEXX Q4 adjusted EPS rose 10% YoY to $2.53, beating the $2.40 estimate. Revenue grew 6% to $954.3M, surpassing the $934.99M consensus. 2025 revenue guidance set at $4.055B–$4.170B vs. $4.14B ...